Cargando…
Using G6PD tests to enable the safe treatment of Plasmodium vivax infections with primaquine on the Thailand-Myanmar border: A cost-effectiveness analysis
BACKGROUND: Primaquine is the only licensed antimalarial for the radical cure of Plasmodium vivax infections. Many countries, however, do not administer primaquine due to fear of hemolysis in those with glucose-6-phosphate dehydrogenase (G6PD) deficiency. In other settings, primaquine is given witho...
Autores principales: | Devine, Angela, Parmiter, Minnie, Chu, Cindy S., Bancone, Germana, Nosten, François, Price, Ric N., Lubell, Yoel, Yeung, Shunmay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5460895/ https://www.ncbi.nlm.nih.gov/pubmed/28542194 http://dx.doi.org/10.1371/journal.pntd.0005602 |
Ejemplares similares
-
Characterization of G6PD Genotypes and Phenotypes on the Northwestern Thailand-Myanmar Border
por: Bancone, Germana, et al.
Publicado: (2014) -
The reality of using primaquine
por: Burgoine, Kathy L, et al.
Publicado: (2010) -
Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria
por: Watson, James, et al.
Publicado: (2018) -
Severe Falciparum and Vivax Malaria on the Thailand-Myanmar Border: A Review of 1503 Cases
por: Chu, Cindy S, et al.
Publicado: (2023) -
Singapore’s Anopheles sinensis Form A is susceptible to Plasmodium vivax isolates from the western Thailand–Myanmar border
por: Pang, Sook-Cheng, et al.
Publicado: (2017)